{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:22:05Z","timestamp":1793424125642,"version":"4.5.0"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41582-024-01035-w","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:40:26Z","timestamp":1731688826000},"page":"708-723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Intracerebral haemorrhage \u2014 mechanisms, diagnosis and prospects for treatment and prevention"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-3849","authenticated-orcid":false,"given":"David J.","family":"Seiffge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9043-0378","authenticated-orcid":false,"given":"Simon","family":"Fandler-H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5800-116X","authenticated-orcid":false,"given":"Martina B.","family":"Goeldlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-9050","authenticated-orcid":false,"given":"Wilmar M. T.","family":"Jolink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8495-4578","authenticated-orcid":false,"given":"Catharina J. M.","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-1861","authenticated-orcid":false,"given":"David J.","family":"Werring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators.","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20, 795\u2013820 (2021).","journal-title":"Lancet Neurol."},{"key":"1035_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","volume":"9","author":"CJ van Asch","year":"2010","unstructured":"van Asch, C. J. et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 9, 167\u2013176 (2010).","journal-title":"Lancet Neurol."},{"key":"1035_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","volume":"85","author":"MT Poon","year":"2014","unstructured":"Poon, M. T., Fonville, A. F. & Al-Shahi Salman, R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 85, 660\u2013667 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5853\/jos.2021.01823","volume":"24","author":"MB Goeldlin","year":"2022","unstructured":"Goeldlin, M. B. et al. Etiology, 3-month functional outcome and recurrent events in non-traumatic intracerebral hemorrhage. J. Stroke 24, 266\u2013277 (2022).","journal-title":"J. Stroke"},{"key":"1035_CR5","doi-asserted-by":"publisher","unstructured":"Foster, L. et al. Effect of deferoxamine on trajectory of recovery after intracerebral hemorrhage: a post hoc analysis of the i-DEF trial. Stroke https:\/\/doi.org\/10.1161\/strokeaha.121.037298 (2022).","DOI":"10.1161\/strokeaha.121.037298"},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaneurol.2022.1991","volume":"79","author":"VA Shah","year":"2022","unstructured":"Shah, V. A. et al. One-year outcome trajectories and factors associated with functional recovery among survivors of intracerebral and intraventricular hemorrhage with initial severe disability. JAMA Neurol. 79, 856\u2013868 (2022).","journal-title":"JAMA Neurol."},{"key":"1035_CR7","doi-asserted-by":"publisher","unstructured":"Ozkan, H. et al. Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30\u2009days after acute stroke: prospective observational hospital cohort study. Int. J. Stroke https:\/\/doi.org\/10.1177\/17474930231215660 (2023).","DOI":"10.1177\/17474930231215660"},{"key":"1035_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324741","author":"M Pasi","year":"2020","unstructured":"Pasi, M. et al. Long-term functional decline of spontaneous intracerebral haemorrhage survivors. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2020-324741 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/17474930221085443","volume":"17","author":"G Scopelliti","year":"2022","unstructured":"Scopelliti, G. et al. Long-term anxiety in spontaneous intracerebral hemorrhage survivors. Int. J. Stroke 17, 1093\u20131099 (2022).","journal-title":"Int. J. Stroke"},{"key":"1035_CR10","first-page":"2127","volume":"15","author":"G Scopelliti","year":"2023","unstructured":"Scopelliti, G. et al. Fatigue after spontaneous intracerebral haemorrhage: prevalence and associated factors. Neurological Sci. 15, 2127\u20132135 (2023).","journal-title":"Neurological Sci."},{"key":"1035_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1474-4422(16)00130-7","volume":"15","author":"S Moulin","year":"2016","unstructured":"Moulin, S. et al. Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study. Lancet Neurol. 15, 820\u2013829 (2016).","journal-title":"Lancet Neurol."},{"key":"1035_CR12","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.118.022606","author":"EJ Tilling","year":"2019","unstructured":"Tilling, E. J., El Tawil, S. & Muir, K. W. Do clinicians overestimate the severity of intracerebral hemorrhage? Stroke https:\/\/doi.org\/10.1161\/strokeaha.118.022606 (2019).","journal-title":"Stroke"},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1161\/STROKEAHA.114.007953","volume":"46","author":"N Samarasekera","year":"2015","unstructured":"Samarasekera, N. et al. Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study. Stroke 46, 361\u2013368 (2015).","journal-title":"Stroke"},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/STROKEAHA.117.019227","volume":"49","author":"A Tamborska","year":"2018","unstructured":"Tamborska, A., Poon, M. T. C. & Al-Shahi Salman, R. Characteristics of randomized trials focusing on stroke due to intracerebral hemorrhage: systematic review. Stroke 49, 594\u2013600 (2018).","journal-title":"Stroke"},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14737175.2019.1623671","volume":"19","author":"IC Hostettler","year":"2019","unstructured":"Hostettler, I. C., Seiffge, D. J. & Werring, D. J. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert. Rev. Neurother. 19, 679\u2013694 (2019).","journal-title":"Expert. Rev. Neurother."},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1212\/WNL.0000000000207510","volume":"101","author":"S Fandler-H\u00f6fler","year":"2023","unstructured":"Fandler-H\u00f6fler, S. et al. Association of the presence and pattern of MRI markers of cerebral small vessel disease with recurrent intracerebral hemorrhage. Neurology 101, e794\u2013e804 (2023).","journal-title":"Neurology"},{"key":"1035_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207977","volume":"102","author":"MB Goeldlin","year":"2024","unstructured":"Goeldlin, M. B. et al. CADMUS. Neurology 102, e207977 (2024).","journal-title":"Neurology"},{"key":"1035_CR18","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou, A. et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology 89, 820\u2013829 (2017).","journal-title":"Neurology"},{"key":"1035_CR19","doi-asserted-by":"publisher","unstructured":"Goeldlin, M. B. et al. Small vessel disease burden and risk of recurrent cerebrovascular events in patients with lacunar stroke and intracerebral haemorrhage attributable to deep perforator arteriolopathy. Eur. Stroke J. https:\/\/doi.org\/10.1177\/23969873231193237 (2023).","DOI":"10.1177\/23969873231193237"},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3171\/2012.7.JNS12281","volume":"117","author":"K Bekelis","year":"2012","unstructured":"Bekelis, K. et al. Computed tomography angiography: improving diagnostic yield and cost effectiveness in the initial evaluation of spontaneous nonsubarachnoid intracerebral hemorrhage. J. Neurosurg. 117, 761\u2013766 (2012).","journal-title":"J. Neurosurg."},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3174\/ajnr.A1546","volume":"30","author":"JE Delgado Almandoz","year":"2009","unstructured":"Delgado Almandoz, J. E. et al. Diagnostic accuracy and yield of multidetector CT angiography in the evaluation of spontaneous intraparenchymal cerebral hemorrhage. AJNR Am. J. Neuroradiol. 30, 1213\u20131221 (2009).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1035_CR22","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1161\/STROKEAHA.113.002386","volume":"44","author":"CJ van Asch","year":"2013","unstructured":"van Asch, C. J. et al. External validation of the secondary intracerebral hemorrhage score in The Netherlands. Stroke 44, 2904\u20132906 (2013).","journal-title":"Stroke"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1161\/STROKEAHA.109.572495","volume":"41","author":"C Cordonnier","year":"2010","unstructured":"Cordonnier, C., Klijn, C. J., van Beijnum, J. & Al-Shahi Salman, R. Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey. Stroke 41, 685\u2013690 (2010).","journal-title":"Stroke"},{"key":"1035_CR24","doi-asserted-by":"publisher","first-page":"h5762","DOI":"10.1136\/bmj.h5762","volume":"351","author":"CJ van Asch","year":"2015","unstructured":"van Asch, C. J. et al. Diagnostic yield and accuracy of CT angiography, MR angiography, and digital subtraction angiography for detection of macrovascular causes of intracerebral haemorrhage: prospective, multicentre cohort study. BMJ 351, h5762 (2015).","journal-title":"BMJ"},{"key":"1035_CR25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00234-007-0252-y","volume":"49","author":"AA Dawkins","year":"2007","unstructured":"Dawkins, A. A. et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology 49, 753\u2013759 (2007).","journal-title":"Neuroradiology"},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1148\/radiol.2433060536","volume":"243","author":"TJ Kaufmann","year":"2007","unstructured":"Kaufmann, T. J. et al. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 243, 812\u2013819 (2007).","journal-title":"Radiology"},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/jnnp-2017-317262","volume":"89","author":"NA Hilkens","year":"2018","unstructured":"Hilkens, N. A. et al. Predicting the presence of macrovascular causes in non-traumatic intracerebral haemorrhage: the DIAGRAM prediction score. J. Neurol. Neurosurg. Psychiatry 89, 674\u2013679 (2018).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209950","volume":"103","author":"S Fandler-H\u00f6fler","year":"2024","unstructured":"Fandler-H\u00f6fler, S. et al. MRI-based prediction of macrovascular causes of intracerebral hemorrhage: the MACRO score. Neurology 103, e209950 (2024).","journal-title":"Neurology"},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ana.26519","volume":"93","author":"N Raposo","year":"2023","unstructured":"Raposo, N. et al. A causal classification system for intracerebral hemorrhage subtypes. Ann. Neurol. 93, 16\u201328 (2023).","journal-title":"Ann. Neurol."},{"key":"1035_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(18)30006-1","volume":"17","author":"MA Rodrigues","year":"2018","unstructured":"Rodrigues, M. A. et al. The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study. Lancet Neurol. 17, 232\u2013240 (2018).","journal-title":"Lancet Neurol."},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1212\/WNL.0000000000207510","volume":"101","author":"ASS Fandler-Hofler","year":"2023","unstructured":"Fandler-Hofler, A. S. S. et al. Association of presence and pattern of MRI markers of cerebral small vessel disease with recurrent intracerebral hemorrhage. Neurology 101, e794\u2013e804 (2023).","journal-title":"Neurology"},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14737175.2022.2104157","volume":"22","author":"M Goeldlin","year":"2022","unstructured":"Goeldlin, M. et al. Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concepts. Expert. Rev. Neurother. 22, 579\u2013594 (2022).","journal-title":"Expert. Rev. Neurother."},{"key":"1035_CR33","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1161\/01.STR.28.7.1418","volume":"28","author":"SM Greenberg","year":"1997","unstructured":"Greenberg, S. M. & Vonsattel, J. P. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 28, 1418\u20131422 (1997).","journal-title":"Stroke"},{"key":"1035_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/alz.12366","volume":"18","author":"L J\u00e4kel","year":"2022","unstructured":"J\u00e4kel, L., De Kort, A. M., Klijn, C. J. M., Schreuder, F. & Verbeek, M. M. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimer\u2019s Dement. 18, 10\u201328 (2022).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1035_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","volume":"21","author":"A Charidimou","year":"2022","unstructured":"Charidimou, A. et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 21, 714\u2013725 (2022).","journal-title":"Lancet Neurol."},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn, J. et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74, 1346\u20131350 (2010).","journal-title":"Neurology"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26761","volume":"94","author":"V Perosa","year":"2023","unstructured":"Perosa, V. et al. Histopathological correlates of lobar microbleeds in false-positive cerebral amyloid angiopathy cases. Ann. Neurol. 94, 856\u2013870 (2023).","journal-title":"Ann. Neurol."},{"key":"1035_CR38","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1212\/WNL.0000000000004797","volume":"90","author":"M Pasi","year":"2018","unstructured":"Pasi, M. et al. Mixed-location cerebral hemorrhage\/microbleeds: underlying microangiopathy and recurrence risk. Neurology 90, e119\u2013e126 (2018).","journal-title":"Neurology"},{"key":"1035_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12975-022-01016-5","volume":"14","author":"WMT Jolink","year":"2023","unstructured":"Jolink, W. M. T. et al. Histopathology of cerebral microinfarcts and microbleeds in spontaneous intracerebral hemorrhage. Transl. stroke Res. 14, 174\u2013184 (2023).","journal-title":"Transl. stroke Res."},{"key":"1035_CR40","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1161\/STROKEAHA.120.031471","volume":"52","author":"K Malhotra","year":"2021","unstructured":"Malhotra, K. et al. Prevalence, characteristics, and outcomes of undetermined intracerebral hemorrhage: a systematic review and meta-analysis. Stroke 52, 3602\u20133612 (2021).","journal-title":"Stroke"},{"key":"1035_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.117.017072","author":"GJ Falcone","year":"2017","unstructured":"Falcone, G. J. & Woo, D. Genetics of spontaneous intracerebral hemorrhage. Stroke https:\/\/doi.org\/10.1161\/strokeaha.117.017072 (2017).","journal-title":"Stroke"},{"key":"1035_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2010.02.016","volume":"473","author":"RJ Caselli","year":"2010","unstructured":"Caselli, R. J., Walker, D., Sue, L., Sabbagh, M. & Beach, T. Amyloid load in nondemented brains correlates with APOE \u03b54. Neurosci. Lett. 473, 168\u2013171 (2010).","journal-title":"Neurosci. Lett."},{"key":"1035_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamaneurol.2021.5205","volume":"79","author":"M Filippi","year":"2022","unstructured":"Filippi, M. et al. Amyloid-related imaging abnormalities and \u03b2-amyloid-targeting antibodies: a systematic review. JAMA Neurol. 79, 291\u2013304 (2022).","journal-title":"JAMA Neurol."},{"key":"1035_CR44","doi-asserted-by":"publisher","first-page":"874962","DOI":"10.3389\/fnins.2022.874962","volume":"16","author":"H Guo","year":"2022","unstructured":"Guo, H. et al. Genetics of spontaneous intracerebral hemorrhage: risk and outcome. Front. Neurosci. 16, 874962 (2022).","journal-title":"Front. Neurosci."},{"key":"1035_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ajhg.2014.02.012","volume":"94","author":"D Woo","year":"2014","unstructured":"Woo, D. et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. Am. J. Hum. Genet. 94, 511\u2013521 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"1035_CR46","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/ana.22403","volume":"69","author":"M Fornage","year":"2011","unstructured":"Fornage, M. et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann. Neurol. 69, 928\u2013939 (2011).","journal-title":"Ann. Neurol."},{"key":"1035_CR47","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1093\/brain\/awad193","volume":"146","author":"G Banerjee","year":"2023","unstructured":"Banerjee, G. et al. Clinical considerations in early-onset cerebral amyloid angiopathy. Brain. 146, 3991\u20134014 (2023).","journal-title":"Brain."},{"key":"1035_CR48","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1212\/WNL.0000000000201720","volume":"100","author":"A Manini","year":"2023","unstructured":"Manini, A. & Pantoni, L. Genetic causes of cerebral small vessel diseases: a practical guide for neurologists. Neurology 100, 766\u2013783 (2023).","journal-title":"Neurology"},{"key":"1035_CR49","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2990.2010.01147.x","volume":"37","author":"Y Yamamoto","year":"2011","unstructured":"Yamamoto, Y., Craggs, L., Baumann, M., Kalimo, H. & Kalaria, R. N. Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol. Appl. Neurobiol. 37, 94\u2013113 (2011).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1035_CR50","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1007\/s00415-018-9072-8","volume":"265","author":"A Bersano","year":"2018","unstructured":"Bersano, A. et al. The role of clinical and neuroimaging features in the diagnosis of CADASIL. J. Neurol. 265, 2934\u20132943 (2018).","journal-title":"J. Neurol."},{"key":"1035_CR51","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.120.030664","author":"YC Liao","year":"2021","unstructured":"Liao, Y. C. et al. Intracerebral hemorrhage in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: prevalence, clinical and neuroimaging features and risk factors. Stroke https:\/\/doi.org\/10.1161\/strokeaha.120.030664 (2021).","journal-title":"Stroke"},{"key":"1035_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clineuro.2017.02.015","volume":"155","author":"CB Sondergaard","year":"2017","unstructured":"Sondergaard, C. B., Nielsen, J. E., Hansen, C. K. & Christensen, H. Hereditary cerebral small vessel disease and stroke. Clin. Neurol. Neurosurg. 155, 45\u201357 (2017).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1035_CR53","doi-asserted-by":"publisher","unstructured":"Buss, L. et al. Intracerebral haemorrhage in Down syndrome: protected or predisposed? F1000Res 5, https:\/\/doi.org\/10.12688\/f1000research.7819.1 (2016).","DOI":"10.12688\/f1000research.7819.1"},{"key":"1035_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1747493020974464","volume":"16","author":"MG Kozberg","year":"2021","unstructured":"Kozberg, M. G., Perosa, V., Gurol, M. E. & van Veluw, S. J. A practical approach to the management of cerebral amyloid angiopathy. Int. J. Stroke 16, 356\u2013369 (2021).","journal-title":"Int. J. Stroke"},{"key":"1035_CR55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-151036","volume":"51","author":"S Chu","year":"2016","unstructured":"Chu, S., Xu, F., Su, Y., Chen, H. & Cheng, X. Cerebral amyloid angiopathy (CAA)-related inflammation: comparison of inflammatory CAA and amyloid-\u03b2-related angiitis. J. Alzheimers Dis. 51, 525\u2013532 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"1035_CR56","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1212\/WNL.0b013e3182a9f545","volume":"81","author":"C Salvarani","year":"2013","unstructured":"Salvarani, C. et al. A\u03b2-related angiitis: comparison with CAA without inflammation and primary CNS vasculitis. Neurology 81, 1596\u20131603 (2013).","journal-title":"Neurology"},{"key":"1035_CR57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/brain\/awh379","volume":"128","author":"NJ Scolding","year":"2005","unstructured":"Scolding, N. J. et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128, 500\u2013515 (2005).","journal-title":"Brain"},{"key":"1035_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaneurol.2015.4078","volume":"73","author":"E Auriel","year":"2016","unstructured":"Auriel, E. et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 73, 197\u2013202 (2016).","journal-title":"JAMA Neurol."},{"key":"1035_CR59","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","volume":"97","author":"L Antolini","year":"2021","unstructured":"Antolini, L. et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy-related inflammation: a multicenter prospective longitudinal cohort study. Neurology 97, e1809\u2013e1822 (2021).","journal-title":"Neurology"},{"key":"1035_CR60","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jamaneurol.2020.1782","volume":"77","author":"RW Regenhardt","year":"2020","unstructured":"Regenhardt, R. W. et al. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 77, 1261\u20131269 (2020).","journal-title":"JAMA Neurol."},{"key":"1035_CR61","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.arr.2019.100916","volume":"53","author":"A Low","year":"2019","unstructured":"Low, A., Mak, E., Rowe, J. B., Markus, H. S. & O\u2019Brien, J. T. Inflammation and cerebral small vessel disease: a systematic review. Ageing Res. Rev. 53, 100916 (2019).","journal-title":"Ageing Res. Rev."},{"key":"1035_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-328792","author":"G Banerjee","year":"2022","unstructured":"Banerjee, G. et al. Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2022-328792 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR63","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/STROKEAHA.122.041690","volume":"54","author":"K Kaushik","year":"2023","unstructured":"Kaushik, K. et al. Iatrogenic cerebral amyloid angiopathy post neurosurgery: frequency, clinical profile, radiological features, and outcome. Stroke 54, 1214\u20131223 (2023).","journal-title":"Stroke"},{"key":"1035_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577\u2013589 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"1035_CR65","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/STROKEAHA.120.030302","volume":"52","author":"Y Qu","year":"2021","unstructured":"Qu, Y. et al. Association of plasma neurofilament light with small vessel disease burden in nondemented elderly: a longitudinal study. Stroke 52, 896\u2013904 (2021).","journal-title":"Stroke"},{"key":"1035_CR66","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5853\/jos.2017.02565","volume":"20","author":"M Duering","year":"2018","unstructured":"Duering, M. et al. Serum neurofilament light chain levels are related to small vessel disease burden. J. Stroke 20, 228\u2013238 (2018).","journal-title":"J. Stroke"},{"key":"1035_CR67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jnnp-2020-325681","volume":"92","author":"M Egle","year":"2021","unstructured":"Egle, M. et al. Neurofilament light chain predicts future dementia risk in cerebral small vessel disease. J. Neurol. Neurosurg. Psychiatry 92, 582\u2013589 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR68","doi-asserted-by":"publisher","first-page":"23727","DOI":"10.18632\/aging.103927","volume":"12","author":"X Cheng","year":"2020","unstructured":"Cheng, X. et al. Neurofilament light chain predicts risk of recurrence in cerebral amyloid angiopathy-related intracerebral hemorrhage. Aging 12, 23727\u201323738 (2020).","journal-title":"Aging"},{"key":"1035_CR69","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1177\/1747493018806167","volume":"14","author":"LA Perry","year":"2019","unstructured":"Perry, L. A. et al. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: systematic review and meta-analysis of diagnostic test accuracy. Int. J. Stroke 14, 390\u2013399 (2019).","journal-title":"Int. J. Stroke"},{"key":"1035_CR70","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1161\/STROKEAHA.117.018409","volume":"48","author":"AH Katsanos","year":"2017","unstructured":"Katsanos, A. H. et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke 48, 2586\u20132588 (2017).","journal-title":"Stroke"},{"key":"1035_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12028-020-00931-5","volume":"33","author":"S Luger","year":"2020","unstructured":"Luger, S. et al. Diagnostic accuracy of glial fibrillary acidic protein and ubiquitin carboxy-terminal hydrolase-L1 serum concentrations for differentiating acute intracerebral hemorrhage from ischemic stroke. Neurocrit. Care 33, 39\u201348 (2020).","journal-title":"Neurocrit. Care"},{"key":"1035_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01813-5","volume":"17","author":"CH Chen","year":"2020","unstructured":"Chen, C. H., Cheng, Y. W., Chen, Y. F., Tang, S. C. & Jeng, J. S. Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL. J. Neuroinflammation 17, 124 (2020).","journal-title":"J. Neuroinflammation"},{"key":"1035_CR73","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.21694","volume":"66","author":"MM Verbeek","year":"2009","unstructured":"Verbeek, M. M. et al. Cerebrospinal fluid amyloid \u03b240 is decreased in cerebral amyloid angiopathy. Ann. Neurol. 66, 245\u2013249 (2009).","journal-title":"Ann. Neurol."},{"key":"1035_CR74","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00415-012-6520-8","volume":"259","author":"D Renard","year":"2012","unstructured":"Renard, D. et al. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J. Neurol. 259, 2429\u20132433 (2012).","journal-title":"J. Neurol."},{"key":"1035_CR75","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/STROKEAHA.110.579078","volume":"41","author":"EE Smith","year":"2010","unstructured":"Smith, E. E. et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke 41, 1933\u20131938 (2010).","journal-title":"Stroke"},{"key":"1035_CR76","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2016.11.021","volume":"372","author":"A Charidimou","year":"2017","unstructured":"Charidimou, A. et al. The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): development and assessment of reliability. J. Neurol. Sci. 372, 178\u2013183 (2017).","journal-title":"J. Neurol. Sci."},{"key":"1035_CR77","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1161\/STROKEAHA.112.661603","volume":"43","author":"A Meretoja","year":"2012","unstructured":"Meretoja, A. et al. SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 43, 2592\u20132597 (2012).","journal-title":"Stroke"},{"key":"1035_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156992","volume":"11","author":"J Marti-Fabregas","year":"2016","unstructured":"Marti-Fabregas, J. et al. The H-ATOMIC criteria for the etiologic classification of patients with intracerebral hemorrhage. PLoS ONE 11, e0156992 (2016).","journal-title":"PLoS ONE"},{"key":"1035_CR79","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.026","volume":"27","author":"J Marti-Fabregas","year":"2018","unstructured":"Marti-Fabregas, J. et al. SMASH-U versus H-ATOMIC: a head-to-head comparison for the etiologic classification of intracerebral hemorrhage. J. Stroke Cerebrovasc. Dis. 27, 2375\u20132380 (2018).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1035_CR80","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/jnnp.2006.089292","volume":"77","author":"CA Jackson","year":"2006","unstructured":"Jackson, C. A. & Sudlow, C. L. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? J. Neurol. Neurosurg. Psychiatry 77, 1244\u20131252 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR81","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325299","author":"DJ Seiffge","year":"2021","unstructured":"Seiffge, D. J. et al. Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2020-325299 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR82","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/STROKEAHA.121.036233","volume":"53","author":"ES van Etten","year":"2022","unstructured":"van Etten, E. S. et al. Trigger factors for spontaneous intracerebral hemorrhage: a case-crossover study. Stroke 53, 1692\u20131699 (2022).","journal-title":"Stroke"},{"key":"1035_CR83","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104921","volume":"29","author":"H Sallinen","year":"2020","unstructured":"Sallinen, H., Putaala, J. & Strbian, D. Triggering factors in non-traumatic intracerebral hemorrhage. J. Stroke Cerebrovasc. Dis. 29, 104921 (2020).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1035_CR84","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1161\/STROKEAHA.120.030429","volume":"51","author":"MSV Elkind","year":"2020","unstructured":"Elkind, M. S. V., Boehme, A. K., Smith, C. J., Meisel, A. & Buckwalter, M. S. Infection as a stroke risk factor and determinant of outcome after stroke. Stroke 51, 3156\u20133168 (2020).","journal-title":"Stroke"},{"key":"1035_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1474-4422(22)00338-6","volume":"22","author":"A Morotti","year":"2023","unstructured":"Morotti, A. et al. Intracerebral haemorrhage expansion: definitions, predictors, and prevention. Lancet Neurol. 22, 159\u2013171 (2023).","journal-title":"Lancet Neurol."},{"key":"1035_CR86","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","volume":"17","author":"R Al-Shahi Salman","year":"2018","unstructured":"Al-Shahi Salman, R. et al. Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol. 17, 885\u2013894 (2018).","journal-title":"Lancet Neurol."},{"key":"1035_CR87","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/STROKEAHA.119.027451","volume":"51","author":"V Yogendrakumar","year":"2020","unstructured":"Yogendrakumar, V. et al. Redefining hematoma expansion with the inclusion of intraventricular hemorrhage growth. Stroke 51, 1120\u20131127 (2020).","journal-title":"Stroke"},{"key":"1035_CR88","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1007\/s00415-019-09536-1","volume":"266","author":"DJ Seiffge","year":"2019","unstructured":"Seiffge, D. J. et al. Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use. J. Neurol. 266, 3126\u20133135 (2019).","journal-title":"J. Neurol."},{"key":"1035_CR89","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1212\/WNL.0000000000002897","volume":"87","author":"D Rodriguez-Luna","year":"2016","unstructured":"Rodriguez-Luna, D. et al. Ultraearly hematoma growth in active intracerebral hemorrhage. Neurology 87, 357\u2013364 (2016).","journal-title":"Neurology"},{"key":"1035_CR90","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1212\/WNL.0b013e3182343387","volume":"77","author":"D Rodriguez-Luna","year":"2011","unstructured":"Rodriguez-Luna, D. et al. Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology 77, 1599\u20131604 (2011).","journal-title":"Neurology"},{"key":"1035_CR91","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1212\/WNL.0b013e3182143317","volume":"76","author":"D Dowlatshahi","year":"2011","unstructured":"Dowlatshahi, D. et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology 76, 1238\u20131244 (2011).","journal-title":"Neurology"},{"key":"1035_CR92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12975-015-0410-1","volume":"6","author":"F Schlunk","year":"2015","unstructured":"Schlunk, F. & Greenberg, S. M. The pathophysiology of intracerebral hemorrhage formation and expansion. Transl. stroke Res. 6, 257\u2013263 (2015).","journal-title":"Transl. stroke Res."},{"key":"1035_CR93","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ana.26481","volume":"92","author":"DJ Seiffge","year":"2022","unstructured":"Seiffge, D. J. et al. Cerebral amyloid angiopathy and the risk of hematoma expansion. Ann. Neurol. 92, 921\u2013930 (2022).","journal-title":"Ann. Neurol."},{"key":"1035_CR94","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/17474930241250259","volume":"19","author":"DJ Seiffge","year":"2024","unstructured":"Seiffge, D. J. & Anderson, C. S. Treatment for intracerebral hemorrhage: dawn of a new era. Int. J. Stroke 19, 482\u2013489 (2024).","journal-title":"Int. J. Stroke"},{"key":"1035_CR95","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s12975-021-00980-8","volume":"13","author":"F Xia","year":"2022","unstructured":"Xia, F. et al. The fate of erythrocytes after cerebral hemorrhage. Transl. Stroke Res. 13, 655\u2013664 (2022).","journal-title":"Transl. Stroke Res."},{"key":"1035_CR96","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(20)30364-1","volume":"19","author":"M Xue","year":"2020","unstructured":"Xue, M. & Yong, V. W. Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation. Lancet Neurol. 19, 1023\u20131032 (2020).","journal-title":"Lancet Neurol."},{"key":"1035_CR97","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/STROKEAHA.122.037155","volume":"54","author":"SN Ohashi","year":"2023","unstructured":"Ohashi, S. N. et al. Role of inflammatory processes in hemorrhagic stroke. Stroke 54, 605\u2013619 (2023).","journal-title":"Stroke"},{"key":"1035_CR98","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/23969873231157884","volume":"8","author":"MP Cliteur","year":"2023","unstructured":"Cliteur, M. P. et al. The association between perihaematomal oedema and functional outcome after spontaneous intracerebral haemorrhage: a systematic review and meta-analysis. Eur. Stroke J. 8, 423\u2013433 (2023).","journal-title":"Eur. Stroke J."},{"key":"1035_CR99","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/jnnp-2021-327098","volume":"93","author":"JJ Loan","year":"2022","unstructured":"Loan, J. J. et al. Secondary injury and inflammation after intracerebral haemorrhage: a systematic review and meta-analysis of molecular markers in patient brain tissue. J. Neurol. Neurosurg. Psychiatry 93, 126\u2013132 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR100","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/23969873231185208","volume":"8","author":"AR Parry-Jones","year":"2023","unstructured":"Parry-Jones, A. R. et al. Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH). Eur. Stroke J. 8, 819\u2013827 (2023).","journal-title":"Eur. Stroke J."},{"key":"1035_CR101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/23969873231200686","volume":"9","author":"MP Cliteur","year":"2024","unstructured":"Cliteur, M. P. et al. Anakinra in cerebral haemorrhage to target secondary injury resulting from neuroinflammation (ACTION): study protocol of a phase II randomised clinical trial. Eur. Stroke J. 9, 265\u2013273 (2024).","journal-title":"Eur. Stroke J."},{"key":"1035_CR102","doi-asserted-by":"publisher","unstructured":"Parry-Jones, A. R. et al. Acute care bundles should be used for patients with intracerebral\u00a0haemorrhage: an expert consensus statement. Eur. Stroke J. https:\/\/doi.org\/10.1177\/23969873231220235 (2023).","DOI":"10.1177\/23969873231220235"},{"key":"1035_CR103","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/STROKEAHA.123.043033","volume":"55","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. Code ICH: a call to action. Stroke 55, 494\u2013505 (2023).","journal-title":"Stroke"},{"key":"1035_CR104","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/ana.25546","volume":"86","author":"AR Parry-Jones","year":"2019","unstructured":"Parry-Jones, A. R. et al. An intracerebral hemorrhage care bundle is associated with lower case fatality. Ann. Neurol. 86, 495\u2013503 (2019).","journal-title":"Ann. Neurol."},{"key":"1035_CR105","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","volume":"402","author":"L Ma","year":"2023","unstructured":"Ma, L. et al. The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet 402, 27\u201340 (2023).","journal-title":"Lancet"},{"key":"1035_CR106","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1373\/clinchem.2016.263335","volume":"63","author":"S Luger","year":"2017","unstructured":"Luger, S. et al. Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clin. Chem. 63, 377\u2013385 (2017).","journal-title":"Clin. Chem."},{"key":"1035_CR107","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1161\/STROKEAHA.121.034592","volume":"52","author":"SR Cooley","year":"2021","unstructured":"Cooley, S. R. et al. Mobile stroke units facilitate prehospital management of intracerebral hemorrhage. Stroke 52, 3163\u20133166 (2021).","journal-title":"Stroke"},{"key":"1035_CR108","doi-asserted-by":"publisher","first-page":"xxvii","DOI":"10.1177\/23969873221079413","volume":"7","author":"S Walter","year":"2022","unstructured":"Walter, S. et al. European Stroke Organisation (ESO) guidelines on mobile stroke units for prehospital stroke management. Eur. Stroke J. 7, xxvii\u2013lix (2022).","journal-title":"Eur. Stroke J."},{"key":"1035_CR109","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/23969873231213156","volume":"9","author":"E Schwabauer","year":"2024","unstructured":"Schwabauer, E. et al. Effects of Mobile Stroke Unit dispatch on blood pressure management and outcomes in patients with intracerebral haematoma: results from the Berlin_Prehospital Or Usual Care Delivery in acute Stroke (B_PROUD) controlled intervention study. Eur. Stroke J. 9, 366\u2013375 (2024).","journal-title":"Eur. Stroke J."},{"key":"1035_CR110","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2314741","volume":"390","author":"G Li","year":"2024","unstructured":"Li, G. et al. Intensive ambulance-delivered blood-pressure reduction in hyperacute stroke. N. Engl. J. Med. 390, 1862\u20131872 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR111","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1161\/STROKEAHA.113.001564","volume":"44","author":"P Langhorne","year":"2013","unstructured":"Langhorne, P. et al. Stroke unit care benefits patients with intracerebral hemorrhage: systematic review and meta-analysis. Stroke 44, 3044\u20133049 (2013).","journal-title":"Stroke"},{"key":"1035_CR112","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209539","volume":"103","author":"J Marti-Fabregas","year":"2024","unstructured":"Marti-Fabregas, J. et al. Influence of hospital type on outcomes of patients with acute spontaneous intracerebral hemorrhage: a population-based study. Neurology 103, e209539 (2024).","journal-title":"Neurology"},{"key":"1035_CR113","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209614","volume":"103","author":"DJ Seiffge","year":"2024","unstructured":"Seiffge, D. J. Good treatment of hyperacute intracerebral hemorrhage is as easy as ABC. Neurology 103, e209614 (2024).","journal-title":"Neurology"},{"key":"1035_CR114","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/01.HYP.0000105052.65787.35","volume":"43","author":"M Willmot","year":"2004","unstructured":"Willmot, M., Leonardi-Bee, J. & Bath, P. M. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43, 18\u201324 (2004).","journal-title":"Hypertension"},{"key":"1035_CR115","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","volume":"368","author":"CS Anderson","year":"2013","unstructured":"Anderson, C. S. et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N. Engl. J. Med. 368, 2355\u20132365 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR116","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","volume":"375","author":"AI Qureshi","year":"2016","unstructured":"Qureshi, A. I. et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N. Engl. J. Med. 375, 1033\u20131043 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR117","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","volume":"18","author":"TJ Moullaali","year":"2019","unstructured":"Moullaali, T. J. et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 18, 857\u2013864 (2019).","journal-title":"Lancet Neurol."},{"key":"1035_CR118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/jnnp-2021-327195","volume":"93","author":"TJ Moullaali","year":"2022","unstructured":"Moullaali, T. J. et al. Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. J. Neurol. Neurosurg. Psychiatry 93, 6\u201313 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR119","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1408827","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver, J. L. et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. N. Engl. J. Med. 372, 528\u2013536 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR120","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S1474-4422(22)00333-7","volume":"21","author":"SA van den Berg","year":"2022","unstructured":"van den Berg, S. A. et al. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial. Lancet Neurol. 21, 971\u2013981 (2022).","journal-title":"Lancet Neurol."},{"key":"1035_CR121","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0140-6736(19)30194-1","volume":"393","author":"R- Investigators","year":"2019","unstructured":"Investigators, R.- Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet 393, 1009\u20131020 (2019).","journal-title":"Lancet"},{"key":"1035_CR122","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg, S. M. et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke 53, e282\u2013e361 (2022).","journal-title":"Stroke"},{"key":"1035_CR123","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1747493020968424","volume":"16","author":"A Shoamanesh","year":"2021","unstructured":"Shoamanesh, A. et al. Canadian stroke best practice recommendations: management of spontaneous intracerebral hemorrhage, 7th edition update 2020. Int. J. Stroke 16, 321\u2013341 (2021).","journal-title":"Int. J. Stroke"},{"key":"1035_CR124","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/ana.25342","volume":"84","author":"G Tsivgoulis","year":"2018","unstructured":"Tsivgoulis, G. et al. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage. Ann. Neurol. 84, 694\u2013704 (2018).","journal-title":"Ann. Neurol."},{"key":"1035_CR125","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1177\/23969873211061975","volume":"6","author":"MB Goeldlin","year":"2021","unstructured":"Goeldlin, M. B. et al. Intracerebral haemorrhage volume, haematoma expansion and 3-month outcomes in patients on antiplatelets. A systematic review and meta-analysis. Eur. Stroke J. 6, 333\u2013342 (2021).","journal-title":"Eur. Stroke J."},{"key":"1035_CR126","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/2396987319849763","volume":"4","author":"H Christensen","year":"2019","unstructured":"Christensen, H. et al. European stroke organisation guideline on reversal of oral anticoagulants in acute intracerebral haemorrhage. Eur. Stroke J. 4, 294\u2013306 (2019).","journal-title":"Eur. Stroke J."},{"key":"1035_CR127","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","volume":"387","author":"MI Baharoglu","year":"2016","unstructured":"Baharoglu, M. I. et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387, 2605\u20132613 (2016).","journal-title":"Lancet"},{"key":"1035_CR128","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/23969873211005915","volume":"6","author":"L Sondag","year":"2021","unstructured":"Sondag, L. et al. Variation in medical management and neurosurgical treatment of patients with supratentorial spontaneous intracerebral haemorrhage. Eur. Stroke J. 6, 134\u2013142 (2021).","journal-title":"Eur. Stroke J."},{"key":"1035_CR129","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1474-4422(23)00157-6","volume":"22","author":"MJR Desborough","year":"2023","unstructured":"Desborough, M. J. R. et al. Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial. Lancet Neurol. 22, 557\u2013567 (2023).","journal-title":"Lancet Neurol."},{"key":"1035_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2023-002813","author":"BM Siepen","year":"2024","unstructured":"Siepen, B. M. et al. Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries. Stroke Vasc. Neurol. https:\/\/doi.org\/10.1136\/svn-2023-002813 (2024).","journal-title":"Stroke Vasc. Neurol."},{"key":"1035_CR131","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","volume":"15","author":"T Steiner","year":"2016","unstructured":"Steiner, T. et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol. 15, 566\u2013573 (2016).","journal-title":"Lancet Neurol."},{"key":"1035_CR132","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jama.2015.0846","volume":"313","author":"JB Kuramatsu","year":"2015","unstructured":"Kuramatsu, J. B. et al. Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA. 313, 824\u2013836 (2015).","journal-title":"JAMA."},{"key":"1035_CR133","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaneurol.2024.0221","volume":"81","author":"KN Sheth","year":"2024","unstructured":"Sheth, K. N. et al. Time to anticoagulation reversal and outcomes after intracerebral hemorrhage. JAMA Neurol. 81, 363\u2013372 (2024).","journal-title":"JAMA Neurol."},{"key":"1035_CR134","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1161\/STROKEAHA.120.030565","volume":"52","author":"AM Demchuk","year":"2021","unstructured":"Demchuk, A. M. et al. Hemostatic efficacy and anti-FXa (factor Xa) reversal with andexanet alfa in intracranial hemorrhage: ANNEXA-4 substudy. Stroke 52, 2096\u20132105 (2021).","journal-title":"Stroke"},{"key":"1035_CR135","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1707278","volume":"377","author":"CV Pollack Jr.","year":"2017","unstructured":"Pollack, C. V. Jr., Reilly, P. A. & Weitz, J. I. Dabigatran reversal with idarucizumab. N. Engl. J. Med. 377, 1691\u20131692 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR136","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/STROKEAHA.121.034572","volume":"53","author":"HB Huttner","year":"2022","unstructured":"Huttner, H. B. et al. Hematoma expansion and clinical outcomes in patients with factor-Xa inhibitor-related atraumatic intracerebral hemorrhage treated within the ANNEXA-4 trial versus real-world usual care. Stroke 53, 532\u2013543 (2022).","journal-title":"Stroke"},{"key":"1035_CR137","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","volume":"390","author":"SJ Connolly","year":"2024","unstructured":"Connolly, S. J. et al. Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage. N. Engl. J. Med. 390, 1745\u20131755 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR138","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1161\/STROKEAHA.123.042866","volume":"54","author":"AA Polymeris","year":"2023","unstructured":"Polymeris, A. A. et al. Tranexamic acid for intracerebral hemorrhage in patients on non-vitamin K antagonist oral anticoagulants (TICH-NOAC): a multicenter, randomized, placebo-controlled, phase 2 trial. Stroke 54, 2223\u20132234 (2023).","journal-title":"Stroke"},{"key":"1035_CR139","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","volume":"380","author":"SJ Connolly","year":"2019","unstructured":"Connolly, S. J. et al. Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N. Engl. J. Med. 380, 1326\u20131335 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR140","doi-asserted-by":"publisher","unstructured":"Siepen, B. M. et al. Andexanet alfa vs non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors \u2014 individual patient data analysis of ANNEXA-4 and TICH-NOAC. Int. J. Stroke https:\/\/doi.org\/10.1177\/17474930241230209 (2024).","DOI":"10.1177\/17474930241230209"},{"key":"1035_CR141","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1474-4422(12)70038-8","volume":"11","author":"AM Demchuk","year":"2012","unstructured":"Demchuk, A. M. et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 11, 307\u2013314 (2012).","journal-title":"Lancet Neurol."},{"key":"1035_CR142","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","volume":"391","author":"N Sprigg","year":"2018","unstructured":"Sprigg, N. et al. Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet 391, 2107\u20132115 (2018).","journal-title":"Lancet"},{"key":"1035_CR143","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1474-4422(20)30369-0","volume":"19","author":"A Meretoja","year":"2020","unstructured":"Meretoja, A. et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 19, 980\u2013987 (2020).","journal-title":"Lancet Neurol."},{"key":"1035_CR144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/svn-2021-000942","volume":"6","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial. Stroke Vasc. Neurol. 6, 160\u2013169 (2021).","journal-title":"Stroke Vasc. Neurol."},{"key":"1035_CR145","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1474-4422(24)00128-5","volume":"23","author":"N Yassi","year":"2024","unstructured":"Yassi, N. et al. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2\u2009h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial. Lancet Neurol. 23, 577\u2013587 (2024).","journal-title":"Lancet Neurol."},{"key":"1035_CR146","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","volume":"358","author":"SA Mayer","year":"2008","unstructured":"Mayer, S. A. et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 358, 2127\u20132137 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR147","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","volume":"76","author":"DJ Gladstone","year":"2019","unstructured":"Gladstone, D. J. et al. Effect of recombinant activated coagulation factor vii on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials. JAMA Neurol. 76, 1493\u20131501 (2019).","journal-title":"JAMA Neurol."},{"key":"1035_CR148","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1161\/STROKEAHA.123.043209","volume":"54","author":"V Yogendrakumar","year":"2023","unstructured":"Yogendrakumar, V., Mayer, S. A., Steiner, T., Broderick, J. P. & Dowlatshahi, D. Exploring hematoma expansion shift with recombinant factor VIIa: a pooled analysis of 4 randomized controlled trials. Stroke 54, 2990\u20132998 (2023).","journal-title":"Stroke"},{"key":"1035_CR149","doi-asserted-by":"publisher","unstructured":"ISRCTN Registry. Tranexamic acid for very early bleeds in the brain. https:\/\/doi.org\/10.1186\/ISRCTN97695350 (2024).","DOI":"10.1186\/ISRCTN97695350"},{"key":"1035_CR150","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05836831 (2024)."},{"key":"1035_CR151","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03044184 (2019)."},{"key":"1035_CR152","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04742205 (2024)."},{"key":"1035_CR153","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03496883 (2024)."},{"key":"1035_CR154","first-page":"Cd005951","volume":"10","author":"H Eilertsen","year":"2023","unstructured":"Eilertsen, H. et al. Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage. Cochrane Database Syst. Rev. 10, Cd005951 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1035_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.11.249","author":"S Sun","year":"2018","unstructured":"Sun, S. et al. The effect of mannitol in the early stage of supratentorial hypertensive intracerebral hemorrhage: a systematic review and meta-analysis. World Neurosurg. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.249 (2018).","journal-title":"World Neurosurg."},{"key":"1035_CR156","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.013","volume":"27","author":"M Shah","year":"2018","unstructured":"Shah, M. et al. Effect of hyperosmolar therapy on outcome following spontaneous intracerebral hemorrhage: Ethnic\/Racial Variations of Intracerebral Hemorrhage (ERICH) study. J. Stroke Cerebrovasc. Dis. 27, 1061\u20131067 (2018).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1035_CR157","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000510040","volume":"49","author":"S Wintzer","year":"2020","unstructured":"Wintzer, S., Heckmann, J. G., Huttner, H. B. & Schwab, S. Dexamethasone in patients with spontaneous intracerebral hemorrhage: an updated meta-analysis. Cerebrovasc. Dis. 49, 495\u2013502 (2020).","journal-title":"Cerebrovasc. Dis."},{"key":"1035_CR158","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1111\/ene.13403","volume":"24","author":"JJ Chang","year":"2017","unstructured":"Chang, J. J. et al. Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study. Eur. J. Neurol. 24, 1384\u20131391 (2017).","journal-title":"Eur. J. Neurol."},{"key":"1035_CR159","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1161\/STROKEAHA.117.018658","volume":"48","author":"AY Fouda","year":"2017","unstructured":"Fouda, A. Y. et al. Minocycline in acute cerebral hemorrhage: an early phase randomized trial. Stroke 48, 2885\u20132887 (2017).","journal-title":"Stroke"},{"key":"1035_CR160","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","volume":"71","author":"Y Fu","year":"2014","unstructured":"Fu, Y. et al. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study. JAMA Neurol. 71, 1092\u20131101 (2014).","journal-title":"JAMA Neurol."},{"key":"1035_CR161","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","volume":"18","author":"M Selim","year":"2019","unstructured":"Selim, M. et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 18, 428\u2013438 (2019).","journal-title":"Lancet Neurol."},{"key":"1035_CR162","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04088630 (2024)."},{"key":"1035_CR163","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-079879","volume":"14","author":"D Gao","year":"2024","unstructured":"Gao, D. et al. Statins for neuroprotection in spontaneous intracerebral haemorrhage (STATIC): protocol for a multicentre, prospective and randomised controlled trial. BMJ open. 14, e079879 (2024).","journal-title":"BMJ open."},{"key":"1035_CR164","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04890379 (2023)."},{"key":"1035_CR165","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03463317 (2021)."},{"key":"1035_CR166","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05263167 (2022)."},{"key":"1035_CR167","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05066620 (2021)."},{"key":"1035_CR168","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05369351 (2024)."},{"key":"1035_CR169","unstructured":"US National Library of Medicine.ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05434065 (2024)."},{"key":"1035_CR170","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1212\/WNL.0b013e31823648a6","volume":"77","author":"V De Herdt","year":"2011","unstructured":"De Herdt, V. et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 77, 1794\u20131800 (2011).","journal-title":"Neurology"},{"key":"1035_CR171","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(22)00235-6","volume":"21","author":"L Peter-Derex","year":"2022","unstructured":"Peter-Derex, L. et al. Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 21, 781\u2013791 (2022).","journal-title":"Lancet Neurol."},{"key":"1035_CR172","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2021.02.029","volume":"87","author":"QK Tran","year":"2021","unstructured":"Tran, Q. K. et al. Preventing seizure occurrence following spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of seizure prophylaxis. Seizure 87, 46\u201355 (2021).","journal-title":"Seizure"},{"key":"1035_CR173","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.25732","volume":"88","author":"L Sondag","year":"2020","unstructured":"Sondag, L. et al. Neurosurgical intervention for supratentorial intracerebral hemorrhage. Ann. Neurol. 88, 239\u2013250 (2020).","journal-title":"Ann. Neurol."},{"key":"1035_CR174","doi-asserted-by":"publisher","unstructured":"Gregson, B. A. et al. Volume reduction with surgery for ICH: when is it effective? Analysis of the CT scans from the STICH II trial. Br. J. Neurosurg. 1\u20138 https:\/\/doi.org\/10.1080\/02688697.2023.2207643 (2023).","DOI":"10.1080\/02688697.2023.2207643"},{"key":"1035_CR175","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/neuros\/nyaa572","volume":"88","author":"SP Polster","year":"2021","unstructured":"Polster, S. P. et al. Intracerebral hemorrhage volume reduction and timing of intervention versus functional benefit and survival in the MISTIE III and STICH trials. Neurosurgery 88, 961\u2013970 (2021).","journal-title":"Neurosurgery"},{"key":"1035_CR176","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1212\/WNL.56.10.1294","volume":"56","author":"LB Morgenstern","year":"2001","unstructured":"Morgenstern, L. B., Demchuk, A. M., Kim, D. H., Frankowski, R. F. & Grotta, J. C. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56, 1294\u20131299 (2001).","journal-title":"Neurology"},{"key":"1035_CR177","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00701-023-05599-2","volume":"165","author":"L Sondag","year":"2023","unstructured":"Sondag, L. et al. Safety and technical efficacy of early minimally invasive endoscopy-guided surgery for intracerebral haemorrhage: the Dutch Intracerebral haemorrhage Surgery Trial pilot study. Acta Neurochir. 165, 1585\u20131596 (2023).","journal-title":"Acta Neurochir."},{"key":"1035_CR178","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2011.2.FOCUS10313","volume":"30","author":"LT Kuo","year":"2011","unstructured":"Kuo, L. T. et al. Early endoscope-assisted hematoma evacuation in patients with supratentorial intracerebral hemorrhage: case selection, surgical technique, and long-term results. Neurosurg. Focus. 30, E9 (2011).","journal-title":"Neurosurg. Focus."},{"key":"1035_CR179","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1161\/STROKEAHA.121.034392","volume":"52","author":"CP Kellner","year":"2021","unstructured":"Kellner, C. P. et al. Time to evacuation and functional outcome after minimally invasive endoscopic intracerebral hemorrhage evacuation. Stroke 52, e536\u2013e539 (2021).","journal-title":"Stroke"},{"key":"1035_CR180","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.wneu.2022.01.084","volume":"161","author":"R Dammers","year":"2022","unstructured":"Dammers, R., Beck, J., Volovici, V., Anderson, C. S. & Klijn, C. J. M. Advancing the surgical treatment of intracerebral hemorrhage: study design and research directions. World Neurosurg. 161, 367\u2013375 (2022).","journal-title":"World Neurosurg."},{"key":"1035_CR181","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2308440","volume":"390","author":"G Pradilla","year":"2024","unstructured":"Pradilla, G. et al. Trial of early minimally invasive removal of intracerebral hemorrhage. N. Engl. J. Med. 390, 1277\u20131289 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR182","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0140-6736(24)00702-5","volume":"403","author":"J Beck","year":"2024","unstructured":"Beck, J. et al. Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial. Lancet 403, 2395\u20132404 (2024).","journal-title":"Lancet"},{"key":"1035_CR183","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/S0140-6736(24)00703-7","volume":"403","author":"CJ Klijn","year":"2024","unstructured":"Klijn, C. J., Dammers, R. & Sprigg, N. Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes? Lancet 403, 2351\u20132353 (2024).","journal-title":"Lancet"},{"key":"1035_CR184","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/STROKEAHA.120.032359","volume":"52","author":"J Lin","year":"2021","unstructured":"Lin, J. & Frontera, J. A. Decompressive hemicraniectomy for large hemispheric strokes. Stroke 52, 1500\u20131510 (2021).","journal-title":"Stroke"},{"key":"1035_CR185","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jama.2019.13014","volume":"322","author":"JB Kuramatsu","year":"2019","unstructured":"Kuramatsu, J. B. et al. Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar intracerebral hemorrhage. JAMA 322, 1392\u20131403 (2019).","journal-title":"JAMA"},{"key":"1035_CR186","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2020-323079","volume":"91","author":"G Banerjee","year":"2020","unstructured":"Banerjee, G. et al. Longer term stroke risk in intracerebral haemorrhage survivors. J. Neurol. Neurosurg. Psychiatry 91, 840\u2013845 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR187","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1474-4422(21)00075-2","volume":"20","author":"L Li","year":"2021","unstructured":"Li, L. et al. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies. Lancet Neurol. 20, 437\u2013447 (2021).","journal-title":"Lancet Neurol."},{"key":"1035_CR188","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.5882","volume":"6","author":"NJ Boe","year":"2023","unstructured":"Boe, N. J. et al. Major cardiovascular events after spontaneous intracerebral hemorrhage by hematoma location. JAMA Netw. open. 6, e235882 (2023).","journal-title":"JAMA Netw. open."},{"key":"1035_CR189","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/STROKEAHA.122.042407","volume":"54","author":"S Fandler-H\u00f6fler","year":"2023","unstructured":"Fandler-H\u00f6fler, S., Gattringer, T., Enzinger, C. & Werring, D. J. Comparison of Boston criteria v2.0\/v1.5 for cerebral amyloid angiopathy to predict recurrent intracerebral hemorrhage. Stroke 54, 1901\u20131905 (2023).","journal-title":"Stroke"},{"key":"1035_CR190","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering, M. et al. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. 22, 602\u2013618 (2023).","journal-title":"Lancet Neurol."},{"key":"1035_CR191","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/jnnp-2021-326116","volume":"92","author":"K Wiegertjes","year":"2021","unstructured":"Wiegertjes, K. et al. Diffusion-weighted imaging lesions and risk of recurrent stroke after intracerebral haemorrhage. J. Neurol. Neurosurg. Psychiatry 92, 950\u2013955 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR192","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/STROKEAHA.120.031628","volume":"52","author":"SB Murthy","year":"2021","unstructured":"Murthy, S. B. et al. Diffusion-weighted imaging lesions after intracerebral hemorrhage and risk of stroke: a MISTIE III and ATACH-2 analysis. Stroke 52, 595\u2013602 (2021).","journal-title":"Stroke"},{"key":"1035_CR193","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jamaneurol.2021.0925","volume":"78","author":"SB Murthy","year":"2021","unstructured":"Murthy, S. B. et al. Association between intracerebral hemorrhage and subsequent arterial ischemic events in participants from 4 population-based cohort studies. JAMA Neurol. 78, 809\u2013816 (2021).","journal-title":"JAMA Neurol."},{"key":"1035_CR194","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S1474-4422(14)70031-6","volume":"13","author":"U Fischer","year":"2014","unstructured":"Fischer, U. et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol. 13, 374\u2013384 (2014).","journal-title":"Lancet Neurol."},{"key":"1035_CR195","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/jama.2015.10082","volume":"314","author":"A Biffi","year":"2015","unstructured":"Biffi, A. et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA 314, 904\u2013912 (2015).","journal-title":"JAMA"},{"key":"1035_CR196","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020392","volume":"10","author":"A Biffi","year":"2021","unstructured":"Biffi, A. et al. Impact of uncontrolled hypertension at 3\u2009months after intracerebral hemorrhage. J. Am. Heart Assoc. 10, e020392 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"1035_CR197","doi-asserted-by":"crossref","unstructured":"PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358, 1033\u20131041 (2001).","DOI":"10.1016\/S0140-6736(01)06178-5"},{"key":"1035_CR198","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","volume":"382","author":"OR Benavente","year":"2013","unstructured":"Benavente, O. R. et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 382, 507\u2013515 (2013).","journal-title":"Lancet"},{"key":"1035_CR199","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","volume":"76","author":"K Kitagawa","year":"2019","unstructured":"Kitagawa, K. et al. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 76, 1309\u20131318 (2019).","journal-title":"JAMA Neurol."},{"key":"1035_CR200","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/STROKEAHA.122.039709","volume":"54","author":"KC Teo","year":"2023","unstructured":"Teo, K. C. et al. Blood pressure control targets and risk of cardiovascular and cerebrovascular events after intracerebral hemorrhage. Stroke 54, 78\u201386 (2023).","journal-title":"Stroke"},{"key":"1035_CR201","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1177\/17474930211068671","volume":"17","author":"CS Anderson","year":"2022","unstructured":"Anderson, C. S. et al. Triple therapy prevention of recurrent intracerebral disease events trial: rationale, design and progress. Int. J. Stroke 17, 1156\u20131162 (2022).","journal-title":"Int. J. Stroke"},{"key":"1035_CR202","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03863665 (2021)."},{"key":"1035_CR203","doi-asserted-by":"publisher","unstructured":"RESTART Collaboration. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Lancet https:\/\/doi.org\/10.1016\/s0140-6736(19)30840-2 (2019).","DOI":"10.1016\/s0140-6736(19)30840-2"},{"key":"1035_CR204","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/jamaneurol.2021.2956","volume":"78","author":"R Al-Shahi Salman","year":"2021","unstructured":"Al-Shahi Salman, R. et al. Effects of antiplatelet therapy after stroke caused by intracerebral hemorrhage: extended follow-up of the RESTART randomized clinical trial. JAMA Neurol. 78, 1179\u20131186 (2021).","journal-title":"JAMA Neurol."},{"key":"1035_CR205","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1474-4422(19)30184-X","volume":"18","author":"R Al-Shahi Salman","year":"2019","unstructured":"Al-Shahi Salman, R. et al. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial. Lancet Neurol. 18, 643\u2013652 (2019).","journal-title":"Lancet Neurol."},{"key":"1035_CR206","doi-asserted-by":"publisher","unstructured":"ISRCTN Registry. The use of aspirin or clopidogrel for people who survive stroke due to bleeding in the brain. https:\/\/doi.org\/10.1186\/ISRCTN16705062 (2024).","DOI":"10.1186\/ISRCTN16705062"},{"key":"1035_CR207","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/ana.25079","volume":"82","author":"A Biffi","year":"2017","unstructured":"Biffi, A. et al. Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann. Neurol. 82, 755\u2013765 (2017).","journal-title":"Ann. Neurol."},{"key":"1035_CR208","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1474-4422(21)00298-2","volume":"20","author":"F Schreuder","year":"2021","unstructured":"Schreuder, F. et al. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Lancet Neurol. 20, 907\u2013916 (2021).","journal-title":"Lancet Neurol."},{"key":"1035_CR209","unstructured":"Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial. Lancet Neurol. 20, 842\u2013853 (2021)."},{"key":"1035_CR210","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","volume":"22","author":"R Al-Shahi Salman","year":"2023","unstructured":"Al-Shahi Salman, R. et al. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials. Lancet Neurol. 22, 1140\u20131149 (2023).","journal-title":"Lancet Neurol."},{"key":"1035_CR211","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","volume":"402","author":"A Shoamanesh","year":"2023","unstructured":"Shoamanesh, A. Anticoagulation in patients with cerebral amyloid angiopathy. Lancet 402, 1418\u20131419 (2023).","journal-title":"Lancet"},{"key":"1035_CR212","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.4244\/EIJ-D-19-00128","volume":"15","author":"A Cresti","year":"2019","unstructured":"Cresti, A. et al. Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroInterventi 15, e225\u2013e230 (2019).","journal-title":"EuroInterventi"},{"key":"1035_CR213","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","volume":"75","author":"P Osmancik","year":"2020","unstructured":"Osmancik, P. et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 75, 3122\u20133135 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1035_CR214","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy, V. Y. et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 312, 1988\u20131998 (2014).","journal-title":"JAMA"},{"key":"1035_CR215","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes, D. R. et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374, 534\u2013542 (2009).","journal-title":"Lancet"},{"key":"1035_CR216","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1212\/WNL.0000000000000022","volume":"82","author":"S Horstmann","year":"2014","unstructured":"Horstmann, S. et al. Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage. Neurology 82, 135\u2013138 (2014).","journal-title":"Neurology"},{"key":"1035_CR217","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-020-00838-5","author":"M Schrag","year":"2020","unstructured":"Schrag, M. et al. Left atrial appendage closure for patients with cerebral amyloid angiopathy and atrial fibrillation: the LAA-CAA cohort. Transl. Stroke Res. https:\/\/doi.org\/10.1007\/s12975-020-00838-5 (2020).","journal-title":"Transl. Stroke Res."},{"key":"1035_CR218","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03243175 (2023)."},{"key":"1035_CR219","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02830152 (2024)."},{"key":"1035_CR220","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02928497 (2024)."},{"key":"1035_CR221","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04676880 (2024)."},{"key":"1035_CR222","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21921","volume":"4","author":"SJ Kittner","year":"2021","unstructured":"Kittner, S. J. et al. Ethnic and racial variation in intracerebral hemorrhage risk factors and risk factor burden. JAMA Netw. Open. 4, e2121921 (2021).","journal-title":"JAMA Netw. Open."},{"key":"1035_CR223","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaneurol.2020.1512","volume":"77","author":"VA Lioutas","year":"2020","unstructured":"Lioutas, V. A. et al. Assessment of incidence and risk factors of intracerebral hemorrhage among participants in the Framingham Heart Study between 1948 and 2016. JAMA Neurol. 77, 1252\u20131260 (2020).","journal-title":"JAMA Neurol."},{"key":"1035_CR224","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa061894","volume":"355","author":"P Amarenco","year":"2006","unstructured":"Amarenco, P. et al. High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355, 549\u2013559 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR225","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/01.wnl.0000327339.55844.1a","volume":"72","author":"S Chaturvedi","year":"2009","unstructured":"Chaturvedi, S. et al. Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology 72, 688\u2013694 (2009).","journal-title":"Neurology"},{"key":"1035_CR226","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","volume":"279","author":"RS Rosenson","year":"1998","unstructured":"Rosenson, R. S. & Tangney, C. C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279, 1643\u20131650 (1998).","journal-title":"JAMA"},{"key":"1035_CR227","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/hq1101.098486","volume":"21","author":"M Takemoto","year":"2001","unstructured":"Takemoto, M. & Liao, J. K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712\u20131719 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1035_CR228","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1160\/TH04-02-0064","volume":"91","author":"A Undas","year":"2004","unstructured":"Undas, A., Celi\u0144ska-L\u00f6wenhoff, M., Kaczor, M. & Musial, J. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb. Haemost. 91, 1065\u20131077 (2004).","journal-title":"Thromb. Haemost."},{"key":"1035_CR229","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.25740","volume":"88","author":"GJ Falcone","year":"2020","unstructured":"Falcone, G. J. et al. Genetically elevated LDL associates with lower risk of intracerebral hemorrhage. Ann. Neurol. 88, 56\u201366 (2020).","journal-title":"Ann. Neurol."},{"key":"1035_CR230","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/brain\/awz413","volume":"143","author":"MK Georgakis","year":"2020","unstructured":"Georgakis, M. K. et al. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. Brain 143, 597\u2013610 (2020).","journal-title":"Brain"},{"key":"1035_CR231","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1212\/WNL.0000000000007853","volume":"93","author":"C Ma","year":"2019","unstructured":"Ma, C. et al. Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: a prospective study. Neurology 93, e445\u2013e457 (2019).","journal-title":"Neurology"},{"key":"1035_CR232","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awac186","volume":"145","author":"E Mayerhofer","year":"2022","unstructured":"Mayerhofer, E. et al. Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk. Brain 145, 2677\u20132686 (2022).","journal-title":"Brain"},{"key":"1035_CR233","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ana.26426","volume":"92","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Lipids, apolipoproteins, statins, and intracerebral hemorrhage: a Mendelian randomization study. Ann. Neurol. 92, 390\u2013399 (2022).","journal-title":"Ann. Neurol."},{"key":"1035_CR234","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jnnp-2018-318483","volume":"90","author":"OJ Ziff","year":"2019","unstructured":"Ziff, O. J., Banerjee, G., Ambler, G. & Werring, D. J. Statins and the risk of intracerebral haemorrhage in patients with stroke: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 90, 75\u201383 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1035_CR235","doi-asserted-by":"publisher","first-page":"e1048","DOI":"10.1212\/WNL.0000000000201664","volume":"100","author":"NJ Boe","year":"2023","unstructured":"Boe, N. J. et al. Association between statin use and intracerebral hemorrhage location: a nested case\u2013control registry study. Neurology 100, e1048\u2013e1061 (2023).","journal-title":"Neurology"},{"key":"1035_CR236","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1910355","volume":"382","author":"P Amarenco","year":"2020","unstructured":"Amarenco, P. et al. A comparison of two LDL cholesterol targets after ischemic stroke. N. Engl. J. Med. 382, 9 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1035_CR237","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03936361 (2024)."},{"key":"1035_CR238","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1161\/STROKEAHA.121.034576","volume":"52","author":"BE Sanz-Cuesta","year":"2021","unstructured":"Sanz-Cuesta, B. E. & Saver, J. L. Lipid-lowering therapy and hemorrhagic stroke risk: comparative meta-analysis of statins and PCSK9 inhibitors. Stroke 52, 3142\u20133150 (2021).","journal-title":"Stroke"},{"key":"1035_CR239","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/STROKEAHA.118.021160","volume":"49","author":"T van Middelaar","year":"2018","unstructured":"van Middelaar, T. et al. Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis. Stroke 49, 1531\u20131533 (2018).","journal-title":"Stroke"},{"key":"1035_CR240","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1111\/jch.14030","volume":"22","author":"Y Lai","year":"2020","unstructured":"Lai, Y. et al. Effect of intensive blood pressure control on the prevention of white matter hyperintensity: systematic review and meta-analysis of randomized trials. J. Clin. Hypertens. 22, 1968\u20131973 (2020).","journal-title":"J. Clin. Hypertens."},{"key":"1035_CR241","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamaneurol.2023.1526","volume":"80","author":"JM Wardlaw","year":"2023","unstructured":"Wardlaw, J. M. et al. Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the Lacunar Intervention Trial-2 (LACI-2) randomized clinical trial. JAMA Neurol. 80, 682\u2013692 (2023).","journal-title":"JAMA Neurol."},{"key":"1035_CR242","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaneurol.2022.2262","volume":"79","author":"HS Markus","year":"2022","unstructured":"Markus, H. S. et al. Framework for clinical trials in cerebral small vessel disease (FINESSE): a review. JAMA Neurol. 79, 1187\u20131198 (2022).","journal-title":"JAMA Neurol."},{"key":"1035_CR243","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/acn3.761","volume":"6","author":"C Leurent","year":"2019","unstructured":"Leurent, C. et al. Immunotherapy with ponezumab for probable cerebral amyloid angiopathy. Ann. Clin. Transl. Neurol. 6, 795\u2013806 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1035_CR244","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.wad.0000213845.28624.f4","volume":"20","author":"SM Greenberg","year":"2006","unstructured":"Greenberg, S. M. et al. A phase 2 study of tramiprosate for cerebral amyloid angiopathy. Alzheimer Dis. Assoc. Disord. 20, 269\u2013274 (2006).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"1035_CR245","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuroscience.2007.01.008","volume":"146","author":"NB Chauhan","year":"2007","unstructured":"Chauhan, N. B. & Siegel, G. J. Antisense inhibition at the \u03b2-secretase-site of \u03b2-amyloid precursor protein reduces cerebral amyloid and acetyl cholinesterase activity in Tg2576. Neuroscience 146, 143\u2013151 (2007).","journal-title":"Neuroscience"},{"key":"1035_CR246","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2019.10.033","volume":"105","author":"SJ van Veluw","year":"2020","unstructured":"van Veluw, S. J. et al. Vasomotion as a driving force for paravascular clearance in the awake mouse brain. Neuron 105, 549\u2013561.e5 (2020).","journal-title":"Neuron"},{"key":"1035_CR247","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06393712 (2024)."},{"key":"1035_CR248","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1161\/STROKEAHA.120.033107","volume":"52","author":"CA Mutimer","year":"2021","unstructured":"Mutimer, C. A. et al. Cerebral amyloid angiopathy and the fibrinolytic system: is plasmin a therapeutic target? Stroke 52, 2707\u20132714 (2021).","journal-title":"Stroke"},{"key":"1035_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07371-4","volume":"24","author":"S Voigt","year":"2023","unstructured":"Voigt, S. et al. Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial. Trials 24, 378 (2023).","journal-title":"Trials"},{"key":"1035_CR250","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033464","volume":"13","author":"F Bax","year":"2024","unstructured":"Bax, F. et al. Minocycline in severe cerebral amyloid angiopathy: a single-center cohort study. J. Am. Heart Assoc. 13, e033464 (2024).","journal-title":"J. Am. Heart Assoc."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01035-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01035-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01035-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:06:02Z","timestamp":1732716362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-024-01035-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":250,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1038\/s41582-024-01035-w","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"11 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DJW reports\u00a0speaking honoraria from Bayer; speaking and chairing honoraria from Alexion and NovoNordisk; and consultancy fees from Alnylam, Bayer and NovoNordisk. He is Co-Chief Investigator for the PROHIBIT-ICH trial. He has participated as a member of\u00a0the LACI-2, TICH-2, TICH-3, RESTART, MACE-ICH and PLINTH Trial Steering Committees.\u00a0The other\u00a0authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}